Polyradiculoneuropathy clinical trials
The registry lists 4 studies for Polyradiculoneuropathy across more than 10 countries. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-18. Counting its 2 narrower conditions too, such as Polyradiculoneuropathy, Chronic Inflammatory Demyelinating: 221 studies, 71 open.
Who runs them
Heinrich-Heine University, Duesseldorf (1) · I.R.C.C.S. Fondazione Santa Lucia (1) · Baxalta now part of Shire (1) · CSL Behring (1)
What is being tested here
Drugs under test in Polyradiculoneuropathy studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Immunoglobulin G | 0 | 1 | 1 |
| Hyaluronoglucosaminidase | 0 | 1 | 1 |
| Immunoglobulins | 0 | 1 | 1 |
Who these studies take
No Polyradiculoneuropathy study is recruiting now.
Across all 4 studies, recruiting or not: 0% stop at 75 or younger and 0% at 65; 0% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. search them.
- Upper Limb Robot-Assisted Therapy in Patients With Guillain-Barré SyndromeActive, not recruitingNCT06620198Phase 41 country
- Electronic Monitoring of Disease Activity in Patients With Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT057238481 country
- A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)CompletedNCT02549170Phase 322 countries
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)CompletedNCT01545076Phase 316 countries